About

This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, VirginiaBio, Inova, Children’s National Health System, QIAGEN, Maryland Tech Council, University System of Maryland and MedImmune/AstraZeneca. Maryland, Virginia, and Washington, DC set the bar high for biotech innovation. So please join us for our Annual BioHealth Capital Region Forum that will highlight the accomplishments of today and chart our successes of tomorrow.

We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.

2018 Agenda

8:00 AM: ARRIVAL

Registration, Breakfast, Networking

8:45 AM: WELCOMING REMARKS

 MODERATORS:
Jeffrey M. Gallagher, CEO, Virginia Bio
Tami Howie, CEO, Maryland Tech Council

8:55 AM: STATE OF THE ECOSYSTEM

KEYNOTE:
Rich Bendis, President & CEO, BioHealth Innovation Inc.

9:15 AM: STRENGTHENING THE UNIVERSITY-CORPORATE CONNECTION – BIOTECH AND BEYOND: A Conversation with University Presidents

MODERATOR:
Brian K. Fitzgerald, EdD, CEO, Business-Higher Education Forum

SPEAKERS:
Ángel Cabrera, President, George Mason University
Dr. Wallace D. Loh, President, University of Maryland, College Park
Jay A. Perman, MD, President, University of Maryland, Baltimore

10:15 AM: UNIVERSITIES: FROM RESEARCH TO COMMERCIALIZATION

MODERATOR:
Christy Wyskiel, Senior Advisor to the President, Johns Hopkins Technology Ventures
PANELISTS:
Eduardo Davila, PhD, Associate Professor, Program Leader Tumor Immunology and Immunotherapy, Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine
Ronald P. Dudek, BS, MBA, ex-Founder & President, Living Pharma, Inc.
Andrew Ishizuka, PhD, Chief Scientific Officer, Avidea Technologies

Geoffrey Lynn, CEO, Avidea Technologies

11:00 AM: NETWORKING BREAK

 

11:30 AM: BIOHEALTH REGIONAL STRENGTHS: IMMUNE-ONCOLOGY, CELL THERAPY & VACCINES

MODERATOR:
John Mumm, PhD, Director, Immunoncology R&D, MedImmune

PANELISTS:
Bill Hearl, CEO, Immunomic Therapeutics, Inc.
Matthew Mulvey, PhD, Founder & CEO, Benevir
Jeffrey Ulmer, PhD, Head, Preclinical R&D, GSK Vaccines

11:30 AM: EMERGING REGIONAL CLUSTERS: DIGITAL HEALTH, DEVICES AND AUGMENTED REALITY

MODERATOR:

William E. Bentley, Robert E. Fischell Distinguished Chair & Inaugural Director of the Robert E. Fischell Institute for Biomedical Devices

PANELISTS:
Dan Gura, PharmD, MPH, Director, Business Development, AlgometRx Inc.
Praduman Jain, BS, MS, Founder & CEO, PI AllofUs Research Program, NIH
Emanuel Petricoin, CSO, Perthera Inc.
Dr. Amitabh Varshney, Dean of the College of Computer, Mathematical and Natural Sciences, University of Maryland

12:30 PM: LUNCH

1:30 PM: ANGEL INVESTORS: WHERE ARE THEY? WHAT DO THEY WANT? HOW DO I ACCESS THEM?

INTRODUCTION BY:
John Trainer, Vice President & Head, Partnering & Strategy, MedImmune

MODERATOR:
Jonathan Aberman, Managing Director, Amplifier Ventures

PANELISTS:
Jeff Galvin, CEO & Founder, American Gene Technologies International Inc.
Merom Klein, Principal, Courage Growth Partners
Paul Silber, PhD, Founding Principal, Blu Venture Investors
Dendy Young, Managing Partner, McLean Capital LLC

2:30 PM: INVESTORS WITH A LOCAL PRESENCE

MODERATOR:
Andy Jones, Chief Investment Officer, TEDCO

PANELISTS:
Mike Thomas, Director, Inova Personalized Health Accelerator (IPHA)
Joel S. Marcus, Chairman, Chief Executive Officer and Founder, Alexandria Real Estate Equities, Inc., and Alexandria Venture Investments
Cherine Eldumiati Plumaker, Managing Director, Pansend Life Sciences, LLC
David A. Present, MD, President & Senior Managing Director, Panned Life Sciences, LLC
R. Jacob Vogelstein, Partner & Portfolio Manager, Camden Partners Holdings, LLC

3:30 PM: NETWORKING BREAK

4:00 PM: NIST’s ROLE IN SETTING STANDARDS THAT TRANSLATE TO MEDICINES FOR PATIENTS

KEYNOTE:
Dr. Walter G. Copan, Under Secretary of Commerce for Standards and Technology and NIST Director

4:20 PM: DAY ONE CLOSING REMARKS

KEYNOTE:
John Trainer, Vice President & Head, Partnering & Strategy, MedImmune

4:30 PM: GENERAL RECEPTION

8:00 AM: ARRIVAL

Registration, Breakfast, Networking

8:30 AM: CREATING COMPANIES FROM AN OPEN SCIENCE ECOSYSTEM

KEYNOTE:
Aled Edwards, PhD, Chief Executive, Structural Genomics Consortium (SGC), University of Toronto

9:00 AM: CRAB TRAP

MODERATOR:
Rich Bendis, President & CEO, BioHealth Innovation Inc.

JUDGES:
Shaun Grady, Vice President, Business Development Operations, AstraZeneca
Sara Nayeem, MD, Partner, New Enterprise Associates
John Rubin, JP Morgan
Paul Silber, PhD, Founding Principal, Blu Venture Investors
Robert Silverman, Head, Externalized Drug Discovery Partnering, Roche
Steven Zachary, Associate, Sands Capital Ventures

10:10 AM: BHCR Spotlight

SPEAKER:
James C. Powers, Chairman & CEO, HemoShear Therapeutics
Michael L. Salgaller, PhD, Supervisor, Invention Development and Marketing Unit, National Cancer Institute, National Institutes of Health

10:20 AM: NETWORKING BREAK

10:45 AM: TALES OF CEOs

MODERATOR:
Barbara Lopez Kunz, MS, Global Chief Executive, DIA

PANELISTS:
Angela Graham, President & CEO, Quality Biological, Inc.
David M. Hilbert, PhD, President & CEO, Arcellx, Inc.
Rachel K. King, Chief Executive Officer, GlycoMimetics, Inc.
Anne S. Lindblad, PhD, President and CEO, The Emmes Corporation

10:45 AM: TALES OF CSOs

MODERATOR:
Steve Projan, PhD, FAAM, Senior Vice President & Head, iMED, Infectious Diseases and Vaccines, MedImmune

PANELISTS:
Olivier Danos, CSO, RegenX Bio
W. James Jackson, Senior Vice President & CSO, Emergent BioSolutions
Ashish Kulkarni, Executive Vice President & Chief Technology Officer, Avantor
Benjamin Solomon, MD, FACMG, Managing Director, GeneDx, Inc.

11:45 AM: LAUNCHING AN AUTOIMMUNE FOCUSED BIOTECH SPINOFF FROM MEDIMMUNE: VIELA BIO

INTRODUCTION:
Lily Qi, Assistant Chief Administrative Officer, Montgomery County Office of the County Executive

KEYNOTE:
Dr. Bing Yao, CEO, Viela Bio

12:05 PM: LUNCH

1:05 PM: PUBLIC SUPPORT FOR BIOHEALTH ENTREPRENEURS

MODERATOR:
Beth Meagher, Deloitte Consulting Principal, Deloitte

PANELISTS:
Rich Bendis, President & CEO, BioHealth Innovation Inc.
Jeffrey M. Gallagher, CEO, Virginia Bio
Tami Howie, CEO, Maryland Tech Council
Jason Miller, CEO, Greater Washington Partnership
Bret Schreiber, Senior Director, Office of BioHealth and Life Sciences, Maryland Department of Commerce

2:00 PM: KEYNOTE FROM SECRETARY OF HEALTH & HUMAN SERVICES, ALEX M. AZAR II

KEYNOTE:

Alex M. Azar II, Secretary, U.S. Department of Health and Human Services

2:20 PM: USING PATIENT INPUT TO DRIVE AND IMPROVE BIOMEDICAL INNOVATION

MODERATOR:
Margaret Anderson, Managing Director, Deloitte Consulting LLP

PANELISTS:
Lisa M. Guay-Woodford, MD, Director, Center for Translational Science, Children’s National Health System
Vasum Peiris, MD, MPH, FAAP, FACC, FASE, Chief Medical Officer, Pediatrics and Special Population, U.S. Food & Drug Administration
Marshall Summar, MD, Director, Rare Disease Institute, Children’s National Medical Center

3:10 PM: ROLE OF HOSPITALS IN CATALYZING HEALTH INNOVATION

MODERATOR:
Tina Reed, Executive Healthcare & Hospitals Editor, FierceHealthcare

SPEAKERS:
Kurt Newman, MD, President & CEO, Children’s National Health System
Todd A. Stottlemyer, CEO, Inova Center for Personalized Health

4:00 PM: CLOSING REMARKS

KEYNOTE:
Rich Bendis, President & CEO, BioHealth Innovation Inc.

2018 Speakers

Jonathan Aberman

Jonathan Aberman

Managing Director, Amplifier Ventures

Margaret Anderson

Margaret Anderson

Managing Director, Deloitte Consulting LLP

Alex M. Azar II

Alex M. Azar II

Secretary, U.S. Department of Health & Human Services

Rich Bendis

Rich Bendis

President and CEO of BioHealth Innovation Inc.

William E. Bentley

William E. Bentley

Robert E. Fishcell Distinguished Chair in Engineering, University of Maryland

Jarrod Borkat

Jarrod Borkat

Senior Director, External Partnerships & Collaborations, MedImmune

Ángel Cabrera

Ángel Cabrera

President, George Mason University

Dr. Walter G. Copan

Dr. Walter G. Copan

Under Secretary of Commerce for Standards and Technology and NIST Director

Olivier Danos, PhD

Olivier Danos, PhD

Chief Scientific Officer, REGENXBIO Inc.

Eduardo Davila, PhD

Eduardo Davila, PhD

Associate Professor, Program Leader Tumor Immunology and Immunotherapy, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore

Ronald P. Dudek, BS, MBA

Ronald P. Dudek, BS, MBA

ex-Founder and President, Living Pharma, Inc.

Aled Edwards, PhD

Aled Edwards, PhD

Chief Executive, Structural Genomics Consortium (SGC), University of Toronto

Brian K. Fitzgerald, Ed.D.

Brian K. Fitzgerald, Ed.D.

CEO, Business-Higher Education Forum

Jeffrey M. Gallagher

Jeffrey M. Gallagher

CEO, Virginia Bio

Jeff Galvin

Jeff Galvin

CEO & Founder, American Gene Technologies International Inc.

Douglas Goldstein

Douglas Goldstein

Managing Director, eFuturist, Inc.

Shaun Grady

Shaun Grady

Vice President, Business Development Operations, AstraZeneca

Angela Graham

Angela Graham

President & CEO, Quality Biological, Inc.

Lisa M. Guay-Woodford, MD

Lisa M. Guay-Woodford, MD

Director, Center for Translational Science, Children's National Health System

Dan Gura, PharmD, MPH

Dan Gura, PharmD, MPH

Director, Business Development, AlgometRx Inc.

Bill Hearl

Bill Hearl

CEO, Immunomic Therapeutics, Inc.

David M. Hilbert, PhD

David M. Hilbert, PhD

President & CEO, Arcellx, Inc.

Tami Howie

Tami Howie

CEO, Maryland Tech Council

Andrew Ishizuka, PhD

Andrew Ishizuka, PhD

Chief Scientific Officer, Avidea Technologies

W. James Jackson

W. James Jackson

Senior Vice President & Chief Scientific Officer, Emergent BioSolutions

Praduman Jain, BS, MS

Praduman Jain, BS, MS

Founder & CEO, PI AllofUs Research Program, NIH

Pete Jobse

Pete Jobse

Managing Director, Inova Strategic Investments / Inova Personalized Health Accelerator

Rachel K. King

Rachel K. King

Chief Executive Officer, GlycoMimetics, Inc.

Merom Klein, PhD

Merom Klein, PhD

Principal, Courage Growth Partners

Barbara Lopez Kunz, MS

Barbara Lopez Kunz, MS

Global Chief Executive, DIA

Anne S. Lindblad, PhD

Anne S. Lindblad, PhD

President and CEO, The Emmes Corporation

Douglas Liu

Douglas Liu

Senior Vice President, Global Operations, Qiagen

Dr. Wallace D. Loh

Dr. Wallace D. Loh

President, University of Maryland, College Park

Geoffrey Lynn, PhD

Geoffrey Lynn, PhD

CEO, Avidea Technologies

Bethany Mancilla

Bethany Mancilla

Vice President, Business Development, Amgen, Inc.

Joel S. Marcus

Joel S. Marcus

Chairman, Chief Executive Officer and Founder, Alexandria Real Estate Equities Inc., and Alexandria Venture Investments

Beth Meagher

Beth Meagher

Deloitte Consulting Principal, Deloitte

Matthew Mulvey, PhD

Matthew Mulvey, PhD

CEO, BeneVir Biopharm, Inc.

Jason Miller

Jason Miller

CEO, Greater Washington Partnership

John Mumm, PhD

John Mumm, PhD

Director, Immunoncology R&D, MedImmune

Sara Nayeem, MD

Sara Nayeem, MD

Partner, New Enterprise Associates

Kurt Newman, MD

Kurt Newman, MD

President & CEO, Children's National Health System

Vasum Peiris, MD, MPH, FAAP, FAAC, FASE

Vasum Peiris, MD, MPH, FAAP, FAAC, FASE

Chief Medical Officer, Pediatrics and Special Populations, U.S. Food & Drug Administration

Jay A. Perman, MD

Jay A. Perman, MD

President, University of Maryland, Baltimore

Emanuel Petricoin

Emanuel Petricoin

Chief Scientific Officer, Perthera, Inc.

James C. Powers

James C. Powers

Chairman & CEO, HemoShear Therapeutics

Cherine Eldumiati Plumaker

Cherine Eldumiati Plumaker

Managing Director, Pansend Life Sciences LLC

David A. Present, MD

David A. Present, MD

President & Senior Managing Director, Pansend Life Sciences LLC

Steve Projan, PhD, FAAM

Steve Projan, PhD, FAAM

Senior Vice President & Head, iMED, Infectious Diseases & Vaccines, MedImmune

Tina Reed

Tina Reed

Executive Healthcare & Hospitals Editor, FierceHealthcare

Michael L. Salgaller, PhD

Michael L. Salgaller, PhD

Supervisor, Invention Development & Marketing Unit, National Cancer Institute, National Institutes of Health

Bret Schreiber

Bret Schreiber

Senior Director, Office of BioHealth and Life Sciences, Maryland Department of Commerce

Paul Silber, PhD

Paul Silber, PhD

Founding Principal, Blu Venture Investors

Robert Silverman

Robert Silverman

Head, External Drug Discovery, Roche Partnering

Benjamin Solomon, MD, FACMG

Benjamin Solomon, MD, FACMG

Managing Director, GeneDx, Inc.

Todd A. Stottlemeyer

Todd A. Stottlemeyer

CEO, Inova Center for Personalized Health

Marshall Summar, MD

Marshall Summar, MD

Director, Rare Disease Institute, Children's National Medical Center

Mike Thomas

Mike Thomas

Director, Inova Personalized Health Accelerator (IPHA)

John Trainer

John Trainer

Vice President, Partnering & Strategy, MedImmune

Jeffrey Ulmer, PhD

Jeffrey Ulmer, PhD

Head, Preclinical R&D, GSK Vaccines

Dr. Amitabh Varshney

Dr. Amitabh Varshney

Dean of the College of Computer, Mathematical, and Natural Sciences, University of Maryland

R. Jacob Vogelstein

R. Jacob Vogelstein

Partner & Portfolio Manager, Camden Parters Holdings, LLC

Christy Wyskiel

Christy Wyskiel

Senior Advisor to the President, Johns Hopkins Technology Ventures

Dr. Bing Yao

Dr. Bing Yao

CEO, Viela Bio

Dendy Young

Dendy Young

Managing Partner, McLean Capital LLC

Crab Trap

2018 BHCR Crab Trap

You thought the Shark Tank was tough…

wait until you enter the the BioHealth Capital Region Crab Trap!

Submit your application for the opportunity to be named the company with the most commercial potential at the 2018 BioHealth Regional Forum.

Application Deadline: March, 30th 2018 

Finalists will be announced: April 9th, 2018 

Finalist Presentations BioHealth Capital Region Forum Event: April 24th, 2018

Submit an Application

Sponsored by:

Present at the BioHealth Capital Region Forum on April 24, 2018
Five finalists will have a chance to win the grand prize by presenting in
front of a panel of prominent industry funding experts and executives including:

  • Rich Bendis (Moderator), President & CEO, BioHealth Innovation, Inc.
  • Shaun Grady, VP, Strategic Partnering & Business Development, AstraZeneca
  • Bethany Mancilla, VP, Business Development, Amgen
  • Sara Nayeem, Partner, New Enterprise Associates (NEA)
  • John T. Rubin, CFA, Executive Director, J.P. Morgan
  • Dr. Paul Silber, Founding Principal, Blu Venture Investors
  • Robert Silverman, Head Externalized Drug Discovery Partnering, Roche
  • Stephen Zachary, Associate, Sands Capital Ventures

    Grand Prize

    $10,000

    Incubation Space in Montgomery County, MD or  Prince William County, VA

    Business Mentoring

    CRITERIA
    Product
    Technical Feasibility
    Marketing/Strategy
    Leadership Team
    Financial/Projection

    APPLY NOW »

Register